The hematopoietic GTPase RhoH acts as a negative regulator for IL-3-induced signals by controlling STAT activity and IL-3 Receptor α expression, ultimately resulting in the preferential activation of STAT1 and decreased cell proliferation in acute myeloid leukemia [33]. The gene discussed is STAT1; the disease is acute myeloid leukemia.